Prediction of individualized lifetime benefit from cardiovascular risk-reducing interventions in apparently healthy people

Affiliations

¹ Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
² Non-Communicable Diseases Research Unit, South African Medical Research Council & University of Cape Town, Cape Town, South Africa.

Editorial

Justin B Echouffo-Tcheugui et al. Eur Heart J. 2020.

. 2020 Mar 14;41(11):1200-1202.

doi: 10.1093/eurheartj/ehz515.

¹ Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
² Non-Communicable Diseases Research Unit, South African Medical Research Council & University of Cape Town, Cape Town, South Africa.

No abstract available

Comment on

Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy people.
Jaspers NEM, Blaha MJ, Matsushita K, van der Schouw YT, Wareham NJ, Khaw KT, Geisel MH, Lehmann N, Erbel R, Jöckel KH, van der Graaf Y, Verschuren WMM, Boer JMA, Nambi V, Visseren FLJ, Dorresteijn JAN. Jaspers NEM, et al. Eur Heart J. 2020 Mar 14;41(11):1190-1199. doi: 10.1093/eurheartj/ehz239. Eur Heart J. 2020. PMID: 31102402 Free PMC article.